Table 1: Demographic and clinic characteristics of groups before the treatment*.

( )
UDCA and domperidone ( )Control ( )

Mean age
Gender (F/M)
BMI (kg/m2)
Glucose (mg/dL)
Cholesterol (mg/dL)
HDL-cholesterol (mg/dL)
LDL-cholesterol (mg/dL)
Triglyceride (mg/dL)
Solitary stone642
Diameters of solitary stones (mm)
Multiple stone161411
FGVav (mL)
RGVav (mL)
EFav (%)

*Results are expressed as mean ± SD.
BMI: body mass index; FGVav: average fasting gallbladder volume; RGVav: average residual gallbladder volume; EFav: average ejection fraction.